ClinicalTrials.Veeva

Menu

Validation of Patient Reported Outcome Measures for Use in Hallux Valgus

Ipsen logo

Ipsen

Status

Completed

Conditions

Hallux Valgus

Study type

Observational

Funder types

Industry

Identifiers

NCT03846687
D-FR-52120-257

Details and patient eligibility

About

The purpose of the study is to explore whether the mFFI is fit for purpose in adults with hallux valgus (HV).

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female, of any race and, aged ≥ 18 years
  • Clinical diagnosis of hallux valgus
  • Fluent in reading/speaking US-English to read and understand informed consent form and to participate in the interview

Exclusion criteria

  • Participation in another foot-based clinical trial in the last 90 days or in Ipsen's clinical trial D-FR-52120-237
  • Current chronic drug or alcohol abuse problem

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems